Prophylactic Cranial Irradiation in Lung Cancer Patients
Author Information
Author(s): Yavuz Ali Aydin, Topkan Erkan, Onal Cem, Yavuz Melek Nur
Primary Institution: Baskent University Medical Faculty, Adana Medical and Research Center, Department of Radiation Oncology, Adana, Turkey
Hypothesis
The study evaluates the usefulness of prophylactic cranial irradiation (PCI) in RPA Group 1 patients with locally advanced non-small cell lung cancer (LA-NSCLC).
Conclusion
Patients with LA-NSCLC in RPA Group 1 who received PCI showed a longer survival and reduced risk of brain metastases.
Supporting Evidence
- 9.7% of patients developed brain metastases during follow-up.
- Median brain metastasis-free survival was 16.7 months.
- Overall survival was also 16.7 months.
Takeaway
This study looked at patients with lung cancer and found that a specific type of radiation treatment can help them live longer and avoid brain problems.
Methodology
The study involved a retrospective analysis of 62 patients treated with chemoradiotherapy and PCI.
Potential Biases
The non-randomized nature of the study may introduce bias.
Limitations
The study lacked comparative neurocognitive assessments pre- and post-PCI.
Participant Demographics
{"gender":{"male":48,"female":14},"age":{"median":59.6,"range":"38-69"},"histology":{"epidermoid":51,"adenocarcinoma":11}}
Statistical Information
P-Value
0.03
Confidence Interval
95% CI: 15.5–17.7 months
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website